2021-22 has been pivotal for the AHSNs and the AHSN Network. While we are still supporting our health and care systems with the recovery from the pandemic, we have undertaken work to set out our vision and strategy and refine our processes to ensure we can meet our collective ambition to transform as many lives as possible through more rapid uptake of high value innovation in health and care.
I summarise our work and priorities over the last year in this overview, you can also read more in our AHSN Network impact report.
Working collaboratively to enhance our collective impact
A focus of our work has included strengthening and further embedding our partnerships with organisations like the National Institute for Healthcare Excellence (NICE), Health Education England (HEE) and NIHR Applied Research Collaboration (ARCs), with joint programmes of work.
We have continued to work closely and collaboratively with our commissioners – NHS England and NHS Improvement, and the Government’s Office for Life Sciences – to co-produce our programmes. We were pleased to welcome colleagues from NHS England and NHS Improvement, and the Accelerated Access Collaborative (AAC) for a series of visits to highlight the achievements of our 15 AHSNs across their geographies and some of the impacts we’ve achieved on a national scale.
More than 480,000 patients benefiting from our national innovation programmes
We have continued with our national programmes and initiatives, including our work to improve ADHD diagnosis for children; increase early intervention for those with eating disorders; enhance the prevention and management of cardiovascular disease; and transform asthma care pathways.
More than 480,000 patients have benefitted through all these programmes of work and other national initiatives.
Through the delivery of the National Patient Safety Improvement Programmes, our Patient Safety Collaboratives have focused on promoting positive safety culture; supporting evidence-based, quality improvement methodology; and encouraging system-level change.
Supporting innovators to grow – leveraging £455m of investment into the economy
Throughout the pandemic, the health and care system saw the impact of life sciences and rapid deployment of innovation on the health of the population. We have undertaken work to refine our ‘universal offer’ for innovators, and are a key development partner in the AAC’s NHS Innovation Service, which will help innovators develop and deploy their innovations to clinicians and patients faster. This year we supported more than 2,400 innovators in their journey to get their innovations adopted by the NHS – helping to leverage £455m of investment into the economy.
Cross-cutting priorities that underpin all our programmes of work
As well as our national innovation and improvement programmes and innovator support, over the last year we’ve also driven forward work on some essential NHS priorities including diversity and inclusion; health inequalities supporting Core20PLUS5; better enabling the adoption of digital and artificial intelligence solutions; and helping to share innovative approaches to help the NHS achieve net zero.
Lastly, I’d like to thank my colleagues from across the Network and our partners for their continued support this year. We know that team working is key to health system transformation and our achievements are only possible together.
Read the full impact report for 2021-22.
Health Secretary Wes Streeting has outlined three strategic shifts for the NHS: transitioning from analogue to digital, moving care from hospitals to communities, and prioritising prevention over treatment. Cardiovascular disease (CVD) presents a significant opportunity to drive these changes, benefiting both public health and the economy. CVD is arguably the big-ticket item for delivering on [...]
Angie Doshani, is founder of JanamApp and Consultant Obstetrician and Gynaecologist at University Hospitals of Leicester NHS Trust. JanamApp is a ground-breaking solution addressing the disparities in pregnancy outcomes faced by South Asian women, who experience a 1.8 times higher risk compared to their white counterparts. The challenges of some women from this demographic include [...]
Lesley Bull, a South London GP and our 1000th delegate chats to Lois-Hooper Ainsworth, Programme Coordinator on the National Polypharmacy Programme, about why she registered for the Health Innovation Network Polypharmacy Action Learning Set, what she got out of it and why other GPs should attend. Lesley Bull So, Lesley, could you tell [...]
